Pontifax Management 4 G.P. (2015) Ltd.

Related Filers (20)

Ownership (20)

SC 13G
Tuesday, 2/6/2024
Nuvectis Pharma, Inc.: Major Shareholders
4
Wednesday, 11/30/2022
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Wednesday, 11/30/2022
Keros Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 5/17/2021
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 4/23/2020
Keros Therapeutics, Inc.: Major Shareholders
4
Monday, 4/13/2020
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/7/2020
Keros Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 11/13/2019
89bio, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/8/2019
89bio, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 9/19/2019
ARQULE INC: Major Shareholders
4
Wednesday, 6/26/2019
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 6/28/2018
ARQULE INC: Major Shareholders
4
Tuesday, 6/19/2018
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/1/2018
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/23/2018
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Tuesday, 1/2/2018
Eloxx Pharmaceuticals, Inc.: Major Shareholders
3
Friday, 12/29/2017
Eloxx Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Show More